Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,080 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ravulizumab and Efgartigimod in Myasthenia Gravis: A Real-World Study.
Stascheit F, Sousa CDF, Aigner A, Behrens M, Keller CW, Klotz L, Lehnerer S, Stein M, Herdick M, Doksani P, Gerischer LM, Hoffmann S, Lazaridis K, Tzartos J, Wiendl H, Meisel A, Lünemann JD. Stascheit F, et al. Among authors: klotz l. Neurol Neuroimmunol Neuroinflamm. 2025 Jan;12(1):e200331. doi: 10.1212/NXI.0000000000200331. Epub 2024 Nov 27. Neurol Neuroimmunol Neuroinflamm. 2025. PMID: 39602677 Free PMC article.
Monoclonal antibodies in neuroinflammatory diseases.
Klotz L, Wiendl H. Klotz L, et al. Expert Opin Biol Ther. 2013 Jun;13(6):831-46. doi: 10.1517/14712598.2013.767329. Epub 2013 Mar 22. Expert Opin Biol Ther. 2013. PMID: 23521026 Review.
Alemtuzumab therapy changes immunoglobulin levels in peripheral blood and CSF.
Möhn N, Pfeuffer S, Ruck T, Gross CC, Skripuletz T, Klotz L, Wiendl H, Stangel M, Meuth SG. Möhn N, et al. Among authors: klotz l. Neurol Neuroimmunol Neuroinflamm. 2019 Dec 11;7(2):e654. doi: 10.1212/NXI.0000000000000654. Print 2020 Mar. Neurol Neuroimmunol Neuroinflamm. 2019. PMID: 31826986 Free PMC article.
Impact of FcγR variants on the response to alemtuzumab in multiple sclerosis.
Keller CW, Ruck T, McHugh D, Pfeuffer S, Gross CC, Korsukewitz C, Melzer N, Klotz L, Meuth SG, Münz C, Nimmerjahn F, Wiendl H, Lünemann JD. Keller CW, et al. Among authors: klotz l. Ann Clin Transl Neurol. 2019 Dec;6(12):2586-2594. doi: 10.1002/acn3.50935. Epub 2019 Nov 4. Ann Clin Transl Neurol. 2019. PMID: 31682087 Free PMC article.
Ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19.
Rolfes L, Pawlitzki M, Pfeuffer S, Nelke C, Lux A, Pul R, Kleinschnitz C, Kleinschnitz K, Rogall R, Pape K, Bittner S, Zipp F, Warnke C, Goereci Y, Schroeter M, Ingwersen J, Aktas O, Klotz L, Ruck T, Wiendl H, Meuth SG. Rolfes L, et al. Among authors: klotz l. Neurol Neuroimmunol Neuroinflamm. 2021 Jul 14;8(5):e1035. doi: 10.1212/NXI.0000000000001035. Print 2021 Sep. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 34261812 Free PMC article.
1,080 results